Altre lingue Surrozen, Inc.

Azioni

SRZN

US86889P1093

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 08/12/2023			Variaz. 5gg	Var. 1 gen.
0,52 ^USD	-3,85%		+6,12%	-10,64%

08/11	Surrozen, Inc. riporta i risultati degli utili per il terzo trimestre e i nove mesi conclusi il 30 settembre 2023	CI
08/11	Surrozen, Inc. prevede di avviare studi clinici di Fase 1a per SZN-043 e SZN-1326 nell'epatite alcolica da moderata a grave	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Surrozen, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	08/11
Surrozen Provides Third Quarter 2023 Financial Results	08/11
Surrozen, Inc. Expects to Initiate A Phase 1a Clinical Trials for SZN-043 and SZN-1326 in Moderate to Severe Alcoholic Hepatitis	08/11
Surrozen, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	09/08
Surrozen Provides Second Quarter 2023 Financial Results	09/08
Surrozen, Inc. Announces Management Changes	19/07
Surrozen, Inc.(NasdaqCM:SRZN) dropped from Russell Microcap Value Index	23/06
Surrozen, Inc.(NasdaqCM:SRZN) dropped from Russell 3000E Value Index	23/06
Surrozen, Inc.(NasdaqCM:SRZN) dropped from Russell 3000E Index	23/06
Surrozen, Inc.(NasdaqCM:SRZN) dropped from Russell Microcap Index	23/06
Surrozen Publishes Study in Nature Communications Demonstrating the Promise of a Fzd4 Wnt Antibody in Treating Ischemic Stroke	05/06
Surrozen, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	10/05
SURROZEN, INC./DE : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	10/05
Surrozen Provides First Quarter 2023 Financial Results and Corporate and Pipeline Updates	10/05
SURROZEN, INC./DE : Change in Directors or Principal Officers (form 8-K)	05/04
Surrozen Strengthens Board of Directors with the Appointment of Eric Bjerkholt	05/04
Surrozen, Inc. Announces Appointment of Eric Bjerkholt to its Board	05/04
SURROZEN, INC./DE Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	31/03
SURROZEN, INC./DE : Other Events (form 8-K)	23/03
Surrozen, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	22/03

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Transcript Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Surrozen, Inc.

Azioni

SRZN

US86889P1093

Altre lingue

Filtri